Clinical Trials Browser

Phase 1 × Terminated × MART-1 Antigen × Clear all

NCT00005841 2014-05-22

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 1 Terminated

Uveal Melanoma, Melanoma